Statistics

Total Visits

Views
DO CHRONIC MYELOID LEUKEMIA PATIENTS WITH LATE "WARNING" RESPONSES BENEFIT FROM SWITCHING THERAPY TO A SECOND GENERATION TYROSINE KINASE INHIBITOR?66

Select a period of time:

Number of views in the range

Views
DO CHRONIC MYELOID LEUKEMIA PATIENTS WITH LATE "WARNING" RESPONSES BENEFIT FROM SWITCHING THERAPY TO A SECOND GENERATION TYROSINE KINASE INHIBITOR?28

Views

Views
April 20255
May 20253
June 20251
July 202510
August 20256
September 20253
October 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States12
Brazil8
United Kingdom2
Argentina2
Spain1
Hong Kong1
 

Top cities views

Views
São Paulo2
Cachoeira do Sul1
Cantagalo1
Columbus1
Council Bluffs1
Duque de Caxias1
Eastleigh1
Florianópolis1
Hong Kong1
Paraíso do Tocantins1